Neuroone Medical Technologies (NMTC) Change in Inventory (2020 - 2026)
Neuroone Medical Technologies (NMTC) posted Change in Inventory of $433268.0 for Q1 2026, up 177.28% on a QoQ basis from -$560658.0 in Q4 2025, and up 550.13% year-over-year from $66643.3 in Q1 2025.
Neuroone Medical Technologies (NMTC) Change in Inventory (2020 - 2026) Analysis & Trends
Neuroone Medical Technologies' Change in Inventory history runs 7 years deep, the most recent figure standing at $433268.0 for Q1 2026.
- Quarterly Change in Inventory rose 550.13% year-over-year to $433268.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274808.0 (down 47.45% YoY) and the FY2025 annual result came in at -$398348.0, down 143.85% from the prior year.
- Change in Inventory was $433268.0 for Q1 2026 at Neuroone Medical Technologies, up from -$560658.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $841721.0 in Q3 2024 and bottomed at -$704292.0 in Q4 2024.
- A 5-year average of $110605.9 and a median of $210159.0 in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 3854.2% — and 2024, when it plunged 496.71%.
- Neuroone Medical Technologies' Change in Inventory stood at $199016.0 in 2022, then sank by 159.31% to -$118029.0 in 2023, then plunged by 496.71% to -$704292.0 in 2024, then rose by 20.39% to -$560658.0 in 2025, then surged by 177.28% to $433268.0 in 2026.
- Business Quant data shows NMTC's Change in Inventory at $433268.0 in Q1 2026, -$560658.0 in Q4 2025, and $331604.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 433,268.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433,268.00 |
| Mar 31, 2026 | 433,268.00 |
| Dec 31, 2025 | -560,658.00 |
| Dec 31, 2025 | -560,658.00 |
| Sep 30, 2025 | 331,604.00 |
| Sep 30, 2025 | 331,604.00 |
| Jun 30, 2025 | 70,594.00 |
| Jun 30, 2025 | 70,594.00 |
| Mar 31, 2025 | -96,254.00 |
| Mar 31, 2025 | -96,254.00 |
| Dec 31, 2024 | -704,292.00 |
| Dec 31, 2024 | -704,292.00 |
| Sep 30, 2024 | 841,721.00 |
| Sep 30, 2024 | 841,721.00 |
| Jun 30, 2024 | 481,759.00 |
| Jun 30, 2024 | 481,759.00 |
| Mar 31, 2024 | -296,984.00 |
| Mar 31, 2024 | -296,984.00 |
| Dec 31, 2023 | -118,029.00 |
| Dec 31, 2023 | -118,029.00 |